Vlahovic, V. 2010. Phase II Prospective Study Evaluating the Role of Personalized Chemotherapy Regimens for Chemo-Naive Select Stage IIIB and IV Non-Small Cell Lung Cancer (NSCLC) in Patients Using a Genomic Predictor of Platinum-Resistance to Guide Therapy. Durham, NC: Duke University Medical Center.
Zuiker, A. 2008. Building a Just Culture. http://inside.duke.edu/article.php?IssueID=183&ParentID=17859 (accessed November 22, 2011).
The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials, Board on Health Care Services, Board on Health Sciences Policy, Institute of Medicine "
Appendix B: Gene ExpressionBased Tests Developed at Duke University and Used in Clinical Trials ."
Evolution of Translational Omics: Lessons Learned and the Path Forward . Washington, DC: The National Academies Press,
Please select a format: